- Multiple myeloma (cancer of a kind of white blood cell called plasma cell)
- Hodgkin’s disease (lymphoid tumor)
- Non-Hodgkin’s lymphomas (lymphoid tumors)
- Brain tumors (medulloblastoma, glioblastoma, astrocytoma, and metastatic brain tumors)
CARNUMAX 100MG
| MRP | : |
|
| Price | : | ₹3,800.00 |
| You Save | : | ₹1,000.00 (20.83%) |
1 Vial(s)
Carnumax 100mg Injection is classified as an Antineoplastic medication. It contains the active ingredient carmustine. This injection is utilized as palliative care, aimed at alleviating the suffering of patients with specific cancers, including multiple myeloma, Hodgkin’s disease, non-Hodgkin’s lymphomas, and various brain tumors such as glioblastoma, medulloblastoma, astrocytoma, and metastatic brain tumors.
Cancer is characterized by the uncontrolled and abnormal proliferation of cells. This medication may be administered alone or in conjunction with other cancer treatments.
Common side effects associated with Carnumax 100mg Injection include headache, dizziness, blurred vision, eye redness, nausea, vomiting, darkening of nails or skin, decreased blood pressure, vein inflammation, constipation, diarrhea, hair loss, anemia, skin flushing, and lack of voluntary muscle coordination. If these side effects are bothersome or persist, please inform your doctor.
If you have an allergy to Carnumax 100mg Injection or any of its components, notify your physician. This medication is contraindicated for individuals with low levels of blood platelets, white blood cells, red blood cells, or those with kidney dysfunction. The use of this medicine may lead to delayed bone marrow suppression and lung damage. Your doctor will regularly monitor your blood counts as well as liver and kidney function. It is important to inform your doctor if you have epilepsy, liver issues, or a history of alcohol addiction, as this medication contains alcohol. Carnumax 100mg Injection is not recommended for use during pregnancy or while breastfeeding.
